Medicines advice

Search Filters

Know what are you looking for?

Submission type

British National Formulary - Chapter

Pharmaceutical company

From

To

Advice

Accepted Not recommended Restricted Superseded Withdrawn Interim acceptance

Process

End of life/orphan Ultra orphan

Additional Details

Patient Access Scheme

Advanced Search

SMC ID	Date	Medicine	Submission Type	Indication
1137/16	11/04/2016	alendronic acid (Binosto)	Abbreviated	for the treatment of postmenopausal osteoporosis. Binosto 70 mg reduces the risk of vertebral and hip fractures.

No medicines have been found